COVID-19 Booster Incentives
1 other identifier
interventional
57,893
1 country
1
Brief Summary
The goal of this work is to understand whether small financial incentives and messaging can increase the take-up of COVID-19 boosters among patients empaneled at a county public health system. The motivation for this work is the relatively low take-up of COVID-19 boosters. In California, where our experiment is based, only 59% of the population has been boosted, with only 13% receiving the recommended bivalent booster (State of California, 2022).
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for not_applicable
Started Dec 2022
Shorter than P25 for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
December 8, 2022
CompletedStudy Start
First participant enrolled
December 8, 2022
CompletedFirst Posted
Study publicly available on registry
December 13, 2022
CompletedPrimary Completion
Last participant's last visit for primary outcome
December 23, 2022
CompletedStudy Completion
Last participant's last visit for all outcomes
December 23, 2022
CompletedAugust 14, 2023
August 1, 2023
15 days
December 8, 2022
August 9, 2023
Conditions
Outcome Measures
Primary Outcomes (1)
Vaccine booster
Received a booster vaccination within 2-weeks of message.
2 weeks
Study Arms (3)
Message Only
EXPERIMENTALEmail or SMS Booster Vaccination Reminder
Message + Financial Incentive
EXPERIMENTALEmail or SMS Booster Vaccination Reminder + Offer of a financial incentive for getting boosted in the next 2 weeks.
Control
PLACEBO COMPARATORNo message or financial incentive
Interventions
Financial Incentive for getting boosted within 2-weeks of the message
Eligibility Criteria
You may qualify if:
- Age: 18 and above
- At least one COVID-19 vaccination (primary series or monovalent booster) but no vaccination dose within the past 2-months.
- Active phone number or email
You may not qualify if:
- \. Opt-out of health system messaging
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- University of Southern Californialead
- J-PAL North Americacollaborator
Study Sites (1)
Contra Costa Health Plan
Martinez, California, 94553, United States
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- SINGLE
- Who Masked
- PARTICIPANT
- Purpose
- HEALTH SERVICES RESEARCH
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Associate Professor
Study Record Dates
First Submitted
December 8, 2022
First Posted
December 13, 2022
Study Start
December 8, 2022
Primary Completion
December 23, 2022
Study Completion
December 23, 2022
Last Updated
August 14, 2023
Record last verified: 2023-08
Data Sharing
- IPD Sharing
- Will share
- Shared Documents
- STUDY PROTOCOL, SAP, ANALYTIC CODE
- Access Criteria
- Researchers can request de-identified data from Contra Costa Health Services.